Drug
Atacicept
Atacicept: highest development phase Phase 2, developed by Vera Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Vera Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Atacicept NCT07020923 | Phase 2 | IgA Nephropathy (IgAN) |
Latest
No recent events.
Follow Atacicept on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.